<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03065140</url>
  </required_header>
  <id_info>
    <org_study_id>16/NS/0024</org_study_id>
    <nct_id>NCT03065140</nct_id>
  </id_info>
  <brief_title>Muscle Fat Compartments and Turnover as Determinant of Insulin Sensitivity</brief_title>
  <acronym>MISTY</acronym>
  <official_title>Muscle Fat Compartments and Turnover as Determinant of Insulin Sensitivity - the MISTY Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aberdeen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NHS Grampian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aberdeen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Early research found that high levels of fat within muscle meant poorer control of blood
      sugar. However, more recent research has shown that athletes have similar levels of fat
      within muscle, but in contrast, they have very good control of blood sugar. The investigators
      are not sure why this is and want to find out if the fat within muscle can be changed to
      improve blood sugar control, as good blood sugar control reduces the risk of heart disease,
      diabetes and stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Higher levels of triglycerides (TG) and diacylglycerols (DAG) are found in skeletal muscle of
      patients with obesity/diabetes as well as in trained athletes. Despite similar metabolic
      storage, patients and athletes have opposite insulin sensitivity phenotypes and an
      explanation for this is lacking. The investigators' objective is to understand how these fat
      compartments can be beneficially modulated to improve insulin resistance and cardio-metabolic
      risk. The investigators will investigate if either structural differences (saturated versus
      unsaturated balance of TG and DAG side-chains) or different handling abilities (fast versus
      slow lipid pool turnover) will be induced by exercise capacity interventions in athletes and
      in diabetic patients. In a longitudinal study pre- and post-exercise, the investigators will
      use novel, non-invasive 1H-Magnetic Resonance Spectroscopy to benchmark the
      saturated/unsaturated compartments against skeletal muscle biopsies for the first time and
      stable isotope analysis for fat compartments' rate of turnover.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Non-invasive 1H Magnetic Resonance Spectroscopy of vastus lateralis</measure>
    <time_frame>One Hour</time_frame>
    <description>Assessment of energetics of vastus lateralis by MRS</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Saturated and unsaturated lipid pool turnover examined by stable isotopes</measure>
    <time_frame>One hour</time_frame>
    <description>Lipid pool turnover as examined by stable isotope infusion</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Healthy volunteers will undergo the following:
CPEX with/without stable isotope infusion
Muscle biopsies
Magnetic Resonance Spectroscopy Followed by a period of detraining.
They will then undergo the following:
CPEX with/without stable isotope infusion
Muscle biopsies
Magnetic Resonance Spectroscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetic Patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diabetic patients will undergo the following:
CPEX with/without stable isotope infusion
Muscle biopsies
Magnetic Resonance Spectroscopy They will then undergo a supervised training period.
They will then undergo the following:
CPEX with/without stable isotope infusion
Muscle biopsies
Magnetic Resonance Spectroscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Training or detraining</intervention_name>
    <description>A period of detraining or a supervised exercise program.</description>
    <arm_group_label>Healthy Volunteers</arm_group_label>
    <arm_group_label>Diabetic Patients</arm_group_label>
    <other_name>Detraining or training</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Type 2 diabetic patients, aged between 20-65, diagnosed as per WHO criteria, diet
             controlled or diet and any of the following oral hypoglycemics: metformin,
             sulphonylureas, glitazones, gliptins, acarbose, but not requiring insulin for
             controlling of blood glucose.

          -  Trained, athletic healthy controls, aged 18 and over.

          -  Participant who is willing and able to give informed consent for participation in the
             study.

          -  Able to perform exercise testing.

        Exclusion Criteria:

          -  Any history of known coronary artery disease.

          -  Other endocrine conditions

          -  Impaired renal function defined as eGFR&lt;60mls/min/1.73m2

          -  Known resting/24 hour BP &gt;160/100mmHg

          -  Participants on ACE inhibitors

          -  Participants on PPAR agonists

          -  Participants on omega 3 fatty acids

          -  The existence of any medical or surgical condition that in the judgement of the
             investigators may interfere with the exercise regime, FA metabolism or may compromise
             the safety of the subject

          -  Presence of other significant concomitant heart diseases such as ischaemic, valvular,
             pericardial heart disease or cardiomyopathy, skeletal muscle disorders

          -  Healthy volunteers that are on any chronic medication that in the judgment of the
             investigators is likely to affect the outcome of the study

          -  Significant asthma

          -  Significant pulmonary disease

          -  Participants unable to cycle on the ergometer

          -  Unable to perform exercise testing (e.g. prosthetic limbs)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dana Dawson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Aberdeen Employee</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dana Dawson, MD</last_name>
    <phone>01224437969</phone>
    <email>dana.dawson@abdn.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alice Mezincescu, MD</last_name>
    <phone>01224559573</phone>
    <email>alice.mezincescu@abdn.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cardiac Research Office</name>
      <address>
        <city>Aberdeen</city>
        <state>Aberdeenshire</state>
        <zip>AB25 2ZN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alice Mezincescu, MD</last_name>
      <phone>01224559573</phone>
      <email>alice.mezincescu@abdn.ac.uk</email>
    </contact>
    <contact_backup>
      <last_name>Amelia Rudd, HND</last_name>
      <phone>01224559573</phone>
      <email>a.e.rudd@abdn.ac.uk</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Lobley GE, Holtrop G, Bremner DM, Calder AG, Milne E, Johnstone AM. Impact of short term consumption of diets high in either non-starch polysaccharides or resistant starch in comparison with moderate weight loss on indices of insulin sensitivity in subjects with metabolic syndrome. Nutrients. 2013 Jun 10;5(6):2144-72. doi: 10.3390/nu5062144.</citation>
    <PMID>23752495</PMID>
  </reference>
  <reference>
    <citation>Wilson FA, van den Borne JJ, Calder AG, O'Kennedy N, Holtrop G, Rees WD, Lobley GE. Tissue methionine cycle activity and homocysteine metabolism in female rats: impact of dietary methionine and folate plus choline. Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E702-13. doi: 10.1152/ajpendo.90670.2008. Epub 2009 Jan 13.</citation>
    <PMID>19141688</PMID>
  </reference>
  <reference>
    <citation>Phillips DI, Caddy S, Ilic V, Fielding BA, Frayn KN, Borthwick AC, Taylor R. Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. Metabolism. 1996 Aug;45(8):947-50.</citation>
    <PMID>8769349</PMID>
  </reference>
  <reference>
    <citation>Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, Still CD, Gerhard GS, Han X, Dziura J, Petersen KF, Samuel VT, Shulman GI. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16381-5. doi: 10.1073/pnas.1113359108. Epub 2011 Sep 19.</citation>
    <PMID>21930939</PMID>
  </reference>
  <reference>
    <citation>Goodpaster BH, He J, Watkins S, Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab. 2001 Dec;86(12):5755-61.</citation>
    <PMID>11739435</PMID>
  </reference>
  <reference>
    <citation>Amati F, Dubé JJ, Alvarez-Carnero E, Edreira MM, Chomentowski P, Coen PM, Switzer GE, Bickel PE, Stefanovic-Racic M, Toledo FG, Goodpaster BH. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? Diabetes. 2011 Oct;60(10):2588-97. doi: 10.2337/db10-1221. Epub 2011 Aug 26.</citation>
    <PMID>21873552</PMID>
  </reference>
  <reference>
    <citation>Manco M, Mingrone G, Greco AV, Capristo E, Gniuli D, De Gaetano A, Gasbarrini G. Insulin resistance directly correlates with increased saturated fatty acids in skeletal muscle triglycerides. Metabolism. 2000 Feb;49(2):220-4.</citation>
    <PMID>10690948</PMID>
  </reference>
  <reference>
    <citation>Anastasiou CA, Kavouras SA, Lentzas Y, Gova A, Sidossis LS, Melidonis A. Diabetes mellitus is associated with increased intramyocellular triglyceride, but not diglyceride, content in obese humans. Metabolism. 2009 Nov;58(11):1636-42. doi: 10.1016/j.metabol.2009.05.019. Epub 2009 Jul 16.</citation>
    <PMID>19615699</PMID>
  </reference>
  <reference>
    <citation>Coen PM, Dubé JJ, Amati F, Stefanovic-Racic M, Ferrell RE, Toledo FG, Goodpaster BH. Insulin resistance is associated with higher intramyocellular triglycerides in type I but not type II myocytes concomitant with higher ceramide content. Diabetes. 2010 Jan;59(1):80-8. doi: 10.2337/db09-0988. Epub 2009 Oct 15.</citation>
    <PMID>19833891</PMID>
  </reference>
  <reference>
    <citation>Bergman BC, Perreault L, Hunerdosse DM, Koehler MC, Samek AM, Eckel RH. Increased intramuscular lipid synthesis and low saturation relate to insulin sensitivity in endurance-trained athletes. J Appl Physiol (1985). 2010 May;108(5):1134-41. doi: 10.1152/japplphysiol.00684.2009. Epub 2010 Mar 18.</citation>
    <PMID>20299618</PMID>
  </reference>
  <reference>
    <citation>King DS, Dalsky GP, Clutter WE, Young DA, Staten MA, Cryer PE, Holloszy JO. Effects of exercise and lack of exercise on insulin sensitivity and responsiveness. J Appl Physiol (1985). 1988 May;64(5):1942-6.</citation>
    <PMID>3292505</PMID>
  </reference>
  <reference>
    <citation>Dubé JJ, Amati F, Toledo FG, Stefanovic-Racic M, Rossi A, Coen P, Goodpaster BH. Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide. Diabetologia. 2011 May;54(5):1147-56. doi: 10.1007/s00125-011-2065-0. Epub 2011 Feb 17.</citation>
    <PMID>21327867</PMID>
  </reference>
  <reference>
    <citation>Dubé JJ, Amati F, Stefanovic-Racic M, Toledo FG, Sauers SE, Goodpaster BH. Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited. Am J Physiol Endocrinol Metab. 2008 May;294(5):E882-8. doi: 10.1152/ajpendo.00769.2007. Epub 2008 Mar 4.</citation>
    <PMID>18319352</PMID>
  </reference>
  <reference>
    <citation>Goodpaster BH, Katsiaras A, Kelley DE. Enhanced fat oxidation through physical activity is associated with improvements in insulin sensitivity in obesity. Diabetes. 2003 Sep;52(9):2191-7.</citation>
    <PMID>12941756</PMID>
  </reference>
  <reference>
    <citation>Summers SA, Nelson DH. A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome. Diabetes. 2005 Mar;54(3):591-602. Review.</citation>
    <PMID>15734832</PMID>
  </reference>
  <reference>
    <citation>Bruce CR, Thrush AB, Mertz VA, Bezaire V, Chabowski A, Heigenhauser GJ, Dyck DJ. Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am J Physiol Endocrinol Metab. 2006 Jul;291(1):E99-E107. Epub 2006 Feb 7.</citation>
    <PMID>16464906</PMID>
  </reference>
  <reference>
    <citation>Brechtel K, Niess AM, Machann J, Rett K, Schick F, Claussen CD, Dickhuth HH, Haering HU, Jacob S. Utilisation of intramyocellular lipids (IMCLs) during exercise as assessed by proton magnetic resonance spectroscopy (1H-MRS). Horm Metab Res. 2001 Feb;33(2):63-6.</citation>
    <PMID>11294494</PMID>
  </reference>
  <reference>
    <citation>Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes. 2001 Jul;50(7):1612-7.</citation>
    <PMID>11423483</PMID>
  </reference>
  <reference>
    <citation>Machann J, Etzel M, Thamer C, Haring HU, Claussen CD, Fritsche A, Schick F. Morning to evening changes of intramyocellular lipid content in dependence on nutrition and physical activity during one single day: a volume selective 1H-MRS study. MAGMA. 2011 Feb;24(1):29-33. doi: 10.1007/s10334-010-0233-8. Epub 2011 Jan 7.</citation>
    <PMID>21213017</PMID>
  </reference>
  <reference>
    <citation>Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol. 1999 Dec;277(6 Pt 1):E1130-41.</citation>
    <PMID>10600804</PMID>
  </reference>
  <reference>
    <citation>Perreault L, Bergman BC, Hunerdosse DM, Playdon MC, Eckel RH. Inflexibility in intramuscular triglyceride fractional synthesis distinguishes prediabetes from obesity in humans. Obesity (Silver Spring). 2010 Aug;18(8):1524-31. doi: 10.1038/oby.2009.454. Epub 2009 Dec 24.</citation>
    <PMID>20035285</PMID>
  </reference>
  <reference>
    <citation>Lizcano JM, Alessi DR. The insulin signalling pathway. Curr Biol. 2002 Apr 2;12(7):R236-8. Review.</citation>
    <PMID>11937037</PMID>
  </reference>
  <reference>
    <citation>Delibegovic M, Bence KK, Mody N, Hong EG, Ko HJ, Kim JK, Kahn BB, Neel BG. Improved glucose homeostasis in mice with muscle-specific deletion of protein-tyrosine phosphatase 1B. Mol Cell Biol. 2007 Nov;27(21):7727-34. Epub 2007 Aug 27.</citation>
    <PMID>17724080</PMID>
  </reference>
  <reference>
    <citation>Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG, Kahn BB. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med. 2006 Aug;12(8):917-24. Epub 2006 Jul 16. Erratum in: Nat Med. 2010 Feb;16(2):237.</citation>
    <PMID>16845389</PMID>
  </reference>
  <reference>
    <citation>Boesch C, Machann J, Vermathen P, Schick F. Role of proton MR for the study of muscle lipid metabolism. NMR Biomed. 2006 Nov;19(7):968-88. Review.</citation>
    <PMID>17075965</PMID>
  </reference>
  <reference>
    <citation>Hock A, Fuchs A, Boesiger P, Kollias SS, Henning A. Electrocardiogram-triggered, higher order, projection-based B₀ shimming allows for fast and reproducible shim convergence in spinal cord ¹H MRS. NMR Biomed. 2013 Mar;26(3):329-35. doi: 10.1002/nbm.2852. Epub 2012 Oct 13.</citation>
    <PMID>23065738</PMID>
  </reference>
  <reference>
    <citation>Hock A, MacMillan EL, Fuchs A, Kreis R, Boesiger P, Kollias SS, Henning A. Non-water-suppressed proton MR spectroscopy improves spectral quality in the human spinal cord. Magn Reson Med. 2013 May;69(5):1253-60. doi: 10.1002/mrm.24387. Epub 2012 Jun 28.</citation>
    <PMID>22745036</PMID>
  </reference>
  <reference>
    <citation>Kuhlmann J, Neumann-Haefelin C, Belz U, Kalisch J, Juretschke HP, Stein M, Kleinschmidt E, Kramer W, Herling AW. Intramyocellular lipid and insulin resistance: a longitudinal in vivo 1H-spectroscopic study in Zucker diabetic fatty rats. Diabetes. 2003 Jan;52(1):138-44.</citation>
    <PMID>12502504</PMID>
  </reference>
  <reference>
    <citation>Ye Q, Danzer CF, Fuchs A, Wolfrum C, Rudin M. Hepatic lipid composition differs between ob/ob and ob/+ control mice as determined by using in vivo localized proton magnetic resonance spectroscopy. MAGMA. 2012 Oct;25(5):381-9. Epub 2012 Mar 23.</citation>
    <PMID>22441585</PMID>
  </reference>
  <reference>
    <citation>van Loon LJ, Koopman R, Manders R, van der Weegen W, van Kranenburg GP, Keizer HA. Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes. Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E558-65. Epub 2004 May 27.</citation>
    <PMID>15165998</PMID>
  </reference>
  <reference>
    <citation>Liu Y, Li J, Zhang Z, Tang Y, Chen Z, Wang Z. Effects of exercise intervention on vascular endothelium functions of patients with impaired glucose tolerance during prediabetes mellitus. Exp Ther Med. 2013 Jun;5(6):1559-1565. Epub 2013 Apr 11.</citation>
    <PMID>23837031</PMID>
  </reference>
  <reference>
    <citation>Dudzinska W, Lubkowska A, Jakubowska K, Suska M, Skotnicka E. Insulin resistance induced by maximal exercise correlates with a post-exercise increase in uridine concentration in the blood of healthy young men. Physiol Res. 2013;62(2):163-70. Epub 2012 Dec 13. Erratum in: Physiol Res. 2013 Jul 18;62(3):337.</citation>
    <PMID>23234409</PMID>
  </reference>
  <reference>
    <citation>Alibegovic AC, Sonne MP, Højbjerre L, Bork-Jensen J, Jacobsen S, Nilsson E, Faerch K, Hiscock N, Mortensen B, Friedrichsen M, Stallknecht B, Dela F, Vaag A. Insulin resistance induced by physical inactivity is associated with multiple transcriptional changes in skeletal muscle in young men. Am J Physiol Endocrinol Metab. 2010 Nov;299(5):E752-63. doi: 10.1152/ajpendo.00590.2009. Epub 2010 Aug 24.</citation>
    <PMID>20739510</PMID>
  </reference>
  <reference>
    <citation>Ducommun S, Wang HY, Sakamoto K, MacKintosh C, Chen S. Thr649Ala-AS160 knock-in mutation does not impair contraction/AICAR-induced glucose transport in mouse muscle. Am J Physiol Endocrinol Metab. 2012 May 15;302(9):E1036-43. doi: 10.1152/ajpendo.00379.2011. Epub 2012 Feb 7.</citation>
    <PMID>22318952</PMID>
  </reference>
  <reference>
    <citation>ECG-Triggered and Respiratory Gated Image Based B0 Shimming for Single Voxel Spectroscopy of the Myocardium at 3T. 21st Annual Meeting and Exhibition of the International Society for Magnetic Resonance in Medicine (ISMRM 2013), Salt Lake City, UT, USA. 2013</citation>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2016</study_first_submitted>
  <study_first_submitted_qc>February 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2017</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin Resistance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

